Cardio-oncology: Understanding the different mechanisms of cardiovascular toxicity
Due to the success of finding treatments for various types of cancer, overall cancer survival has increased substantially in recent decades. Ironically, the clinical success of antineoplastic therapy is attenuated by the comorbidity of cardiovascular diseases, which appear to be the main complicatio...
Main Author: | Júlia Cristina Toste |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-07-01
|
Series: | Revista Portuguesa de Cardiologia |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0870255122002372 |
Similar Items
-
Cardiotoxicidad de los Quimioterapéuticos Diferentes a antraciclinas de la lista oficial de medicamentos de la Caja Costarricense del Seguro Social.
by: Juliana Salas Segura, et al.
Published: (2018-11-01) -
Clinical experience of a cardio-oncology consultation at a tertiary university hospital in Portugal: An observational study
by: Manuela Fiuza, et al.
Published: (2022-12-01) -
Clinical and echocardiographic characteristics of early cardiotoxicity in patients with breast cancer treated with chemotherapy
by: Julio Alberto Pérez Domínguez, et al.
Published: (2022-08-01) -
Disfunción cardiaca subclínica en pacientes oncológicos: Reporte de un caso
by: Enrique Ruiz-Mori, et al.
Published: (2020-01-01) -
Evaluación cardiaca de pacientes con cáncer de mama tratadas con antraciclinas
by: Gilberto Cairo Sáez, et al.
Published: (2017-03-01)